| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction.
|
Circulation
|
1996
|
2.59
|
|
2
|
Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction.
|
Circulation
|
1996
|
2.31
|
|
3
|
Temporal changes in myocardial perfusion patterns in patients with reperfused anterior wall myocardial infarction. Their relation to myocardial viability.
|
Circulation
|
1995
|
1.81
|
|
4
|
Role of oxygen-derived free radicals in myocardial edema and ischemia in coronary microvascular embolization.
|
Circulation
|
1991
|
1.60
|
|
5
|
Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction.
|
J Am Coll Cardiol
|
1997
|
1.28
|
|
6
|
Characterization of superoxide dismutases purified from either anaerobically maintained or aerated Bacteroides gingivalis.
|
J Bacteriol
|
1990
|
1.15
|
|
7
|
Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction.
|
J Am Coll Cardiol
|
1999
|
1.09
|
|
8
|
Spontaneous neoplastic lesions in aged Sprague-Dawley rats.
|
Exp Anim
|
2001
|
1.07
|
|
9
|
Pressure-derived collateral flow index as a parameter of microvascular dysfunction in acute myocardial infarction.
|
J Am Coll Cardiol
|
2001
|
0.99
|
|
10
|
Alpha 1-adrenoceptor activity regulates release of adenosine from the ischemic myocardium in dogs.
|
Circ Res
|
1987
|
0.91
|
|
11
|
Alpha 1-adrenoceptor activation increases ecto-5'-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C.
|
Circulation
|
1995
|
0.89
|
|
12
|
Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint.
|
J Am Coll Cardiol
|
1993
|
0.86
|
|
13
|
Ultrasonic tissue characterization predicts myocardial viability in early stage of reperfused acute myocardial infarction.
|
Circulation
|
1998
|
0.86
|
|
14
|
Effects of phosphorylation of inhibitory GTP-binding protein by cyclic AMP-dependent protein kinase on its ADP-ribosylation by pertussis toxin, islet-activating protein.
|
FEBS Lett
|
1988
|
0.85
|
|
15
|
Effect of transferrin on the growth of Porphyromonas gingivalis.
|
J Dent Res
|
1991
|
0.84
|
|
16
|
Staged reperfusion attenuates myocardial stunning in dogs. Role of transient acidosis during early reperfusion.
|
Circulation
|
1991
|
0.83
|
|
17
|
Assessing the relation between coronary reflow and myocardial reflow.
|
Am J Cardiol
|
1998
|
0.82
|
|
18
|
Prediction of wall motion recovery from the left anterior descending coronary artery velocity pattern recorded by transthoracic doppler echocardiography in patients with anterior wall myocardial infarction retrospective and prospective studies.
|
Jpn Circ J
|
2001
|
0.81
|
|
19
|
Beneficial effects of alpha 1-adrenoceptor activity on myocardial stunning in dogs.
|
Circ Res
|
1991
|
0.79
|
|
20
|
New approach to the estimation of the extent of myocardial fibrosis in patients with dilated cardiomyopathy: use of signal-averaged electrocardiography.
|
Am Heart J
|
1993
|
0.79
|
|
21
|
Beneficial effects of alpha 2-adrenoceptor activity on ischemic myocardium during coronary hypoperfusion in dogs.
|
Circ Res
|
1989
|
0.78
|
|
22
|
Role of alpha 1-adrenoceptor activity in progression of cardiac hypertrophy in guinea pig hearts with pressure overload.
|
Cardiovasc Res
|
1989
|
0.77
|
|
23
|
Combination study of myocardial perfusion and left ventricular filling provides an excellent prediction of clinical outcomes in patients with reperfused myocardial infarction.
|
Basic Res Cardiol
|
2006
|
0.77
|
|
24
|
Temporal changes in regional end-diastolic wall thickness early after reperfusion in acute anterior myocardial infarction: relation to myocardial viability and vascular damage.
|
Am Heart J
|
1996
|
0.77
|
|
25
|
Alpha 2-adrenoceptor activity exerts dual control of coronary blood flow in canine coronary artery.
|
Am J Physiol
|
1988
|
0.77
|
|
26
|
Alpha 2-adrenoceptor stimulation can augment coronary vasodilation maximally induced by adenosine in dogs.
|
Am J Physiol
|
1989
|
0.77
|
|
27
|
The role of Na+/H+ exchange in norepinephrine-induced protein synthesis in neonatal cultured rat cardiomyocytes.
|
Jpn Circ J
|
1990
|
0.76
|
|
28
|
[A 13-week oral toxicity study of prulifloxacin (NM441) in dogs followed by a 5-week recovery test].
|
J Toxicol Sci
|
1996
|
0.75
|
|
29
|
[Renal toxicity of prulifloxacin (NM441) in rats].
|
J Toxicol Sci
|
1996
|
0.75
|
|
30
|
Excretion of new quinolones and their glucuronide conjugates into human bile.
|
Drugs
|
1995
|
0.75
|
|
31
|
[Four-week intravenous toxicity study of montirelin hydrate (NS-3) in dogs followed by 4-week recovery test].
|
J Toxicol Sci
|
1995
|
0.75
|
|
32
|
[A 13-week oral repeated dose toxicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in rats followed by a 5-week recovery test].
|
J Toxicol Sci
|
1997
|
0.75
|
|
33
|
[Single-dose toxicity studies of (+/-)-4-diethylamino-1, 1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in mice, rats and dogs].
|
J Toxicol Sci
|
1997
|
0.75
|
|
34
|
[Five-week intravenous toxicity study of montirelin hydrate (NS-3) in rats followed by 4-week recovery test].
|
J Toxicol Sci
|
1995
|
0.75
|
|
35
|
[Toxicokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in mice and rats during 13-week dietary administration].
|
J Toxicol Sci
|
1997
|
0.75
|
|
36
|
[The mechanism of increased thyroidal function caused by (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, administration in rats].
|
J Toxicol Sci
|
1997
|
0.75
|
|
37
|
Beneficial effect of OPC-8212 (3,4-dihydro-6-(4-(3,4-dimethoxy benzoyl)-1-piperazinyl)-2(1H)-quinolinone on myocardial oxygen consumption in dogs with ischemic heart failure.
|
Jpn Circ J
|
1986
|
0.75
|
|
38
|
[A 4-week oral toxicity study of prulifloxacin (NM441) in rats followed by a 4-week recovery test].
|
J Toxicol Sci
|
1996
|
0.75
|
|
39
|
[A 26-week oral repeated dose toxicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in rats followed by a 9-week recovery test].
|
J Toxicol Sci
|
1997
|
0.75
|
|
40
|
[A 13-week oral repeated dose toxicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in dogs followed by a 5-week recovery test].
|
J Toxicol Sci
|
1997
|
0.75
|
|
41
|
Seventy-eight-week dietary carcinogenicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in mice.
|
J Toxicol Sci
|
1997
|
0.75
|
|
42
|
Effects of lithium ion on the inhibitory GTP-binding protein and its coupling response.
|
Cell Signal
|
1991
|
0.75
|
|
43
|
[A 12-month oral repeated dose toxicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in dogs followed by a 2-month recovery test].
|
J Toxicol Sci
|
1997
|
0.75
|
|
44
|
[A 13-week oral toxicity study of prulifloxacin (NM441) in rats followed by a 5-week recovery test].
|
J Toxicol Sci
|
1996
|
0.75
|
|
45
|
[Single dose toxicity studies of montirelin hydrate(NS-3) in mice, rats and dogs].
|
J Toxicol Sci
|
1995
|
0.75
|
|
46
|
[Twenty-six-week intravenous toxicity study of montirelin hydrate (NS-3) in rats followed by 9-week recovery test].
|
J Toxicol Sci
|
1995
|
0.75
|
|
47
|
[A case of hepatocellular carcinoma fed by the cystic artery treated with chemolipiodolization therapy].
|
Nihon Shokakibyo Gakkai Zasshi
|
2000
|
0.75
|
|
48
|
[A 4-week oral toxicity study of prulifloxacin (NM441) in dogs followed by a 4-week recovery test].
|
J Toxicol Sci
|
1996
|
0.75
|
|
49
|
[Mutagenicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence].
|
J Toxicol Sci
|
1997
|
0.75
|
|
50
|
[Twenty-six-week intravenous toxicity study of montirelin hydrate (NS-3) in dogs followed by 9-week recovery test].
|
J Toxicol Sci
|
1995
|
0.75
|
|
51
|
[Vascular irritability study of montirelin hydrate (NS-3) injection in rabbits].
|
J Toxicol Sci
|
1995
|
0.75
|
|
52
|
[A 4-week intravenous toxicity study of the active metabolite (NM394) of prulifloxacin (NM441) in rats followed by a 4-week recovery test].
|
J Toxicol Sci
|
1996
|
0.75
|
|
53
|
An increase in myocardial beta-adrenoceptors to compensate for postischaemic dysfunction following coronary micro-embolisation in dogs.
|
Cardiovasc Res
|
1989
|
0.75
|
|
54
|
Two-year dietary carcinogenicity study of (+/-)-4-diethylamino-1, 1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in rats.
|
J Toxicol Sci
|
1997
|
0.75
|
|
55
|
Adenosine-induced hyperemia attenuates myocardial ischemia in coronary microembolization in dogs.
|
Am J Physiol
|
1989
|
0.75
|
|
56
|
Enzyme-linked immunosorbent determination of the binding component to salivary glycoprotein from Streptococcus mitis ATCC 9811.
|
J Osaka Univ Dent Sch
|
1987
|
0.75
|
|
57
|
[Intraperitoneal single-dose toxicity studies of active metabolite, optical isomers, hydrolysis products and bi-product of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in mice].
|
J Toxicol Sci
|
1997
|
0.75
|
|
58
|
[Single dose toxicity studies of metabolite, degradation product and impurity of montirelin hydrate (NS-3) in mice].
|
J Toxicol Sci
|
1995
|
0.75
|
|
59
|
Substrate specificity of fucosyltransferase purified from human parotid saliva.
|
J Dent Res
|
1987
|
0.75
|
|
60
|
Role of increased alpha 1-adrenergic activity in cardiomyopathic Syrian hamster.
|
Am J Physiol
|
1991
|
0.75
|
|
61
|
Antecedent angina pectoris as a predictor of better functional and clinical outcomes in patients with an inferior wall acute myocardial infarction.
|
Am J Cardiol
|
1999
|
0.75
|
|
62
|
[Single-dose toxicity studies of prulifloxacin (NM441) in mice, rats and dogs and the active metabolite (NM394) in rats].
|
J Toxicol Sci
|
1996
|
0.75
|
|
63
|
[Oral single-dose and 13-week repeat-dose toxicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in rats].
|
J Toxicol Sci
|
1997
|
0.75
|